Arcadia Biosciences, Inc. (RKDA) financial statements (2022 and earlier)
Company profile
Business Address |
202 COUSTEAU PLACE DAVIS, 95618 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
SIC | 01 - Agricultural Production Crops (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 28,685 | 35,526 | 43,977 | 51,936 | 25,667 | 10,201 | 15,595 | ||
Cash and cash equivalents | 28,685 | 35,526 | 43,977 | 32,848 | 14,042 | 10,201 | 14,995 | ||
Short-term investments | 19,088 | 11,625 | 600 | ||||||
Receivables | 1,370 | 1,453 | 1,147 | 1,113 | 1,406 | 373 | 403 | ||
Inventory, net of allowances, customer advances and progress billings | 4,433 | 5,447 | 3,897 | 2,663 | 3,812 | 9,416 | 8,772 | ||
Inventory | 4,433 | 5,447 | 3,897 | 2,663 | 3,812 | 9,416 | 8,772 | ||
Other undisclosed current assets | 900 | 1,408 | 1,895 | 901 | 811 | 1,204 | 1,326 | ||
Total current assets: | 35,388 | 43,834 | 50,916 | 56,613 | 31,696 | 21,194 | 26,096 | ||
Noncurrent Assets | |||||||||
Inventory, Noncurrent | 2,494 | 3,539 | 3,890 | 4,290 | 3,485 | 461 | 658 | ||
Operating lease, right-of-use asset | 3,081 | 3,486 | 6,360 | 5,636 | 5,826 | 6,013 | 5,598 | ||
Property, plant and equipment | 2,291 | 2,634 | 3,740 | 3,480 | 3,539 | 3,484 | 3,403 | ||
Intangible assets, net (including goodwill) | 484 | 5,553 | 5,716 | 758 | 778 | 701 | |||
Goodwill | 1,648 | 1,648 | 408 | 408 | 301 | ||||
Intangible assets, net (excluding goodwill) | 484 | 3,905 | 4,068 | 350 | 370 | 400 | |||
Restricted cash and investments | 2,001 | 2,001 | 2,000 | ||||||
Other noncurrent assets | 180 | 182 | 176 | 23 | 23 | 23 | 23 | ||
Total noncurrent assets: | 8,530 | 15,394 | 19,882 | 14,187 | 15,652 | 12,683 | 11,682 | ||
TOTAL ASSETS: | 43,918 | 59,228 | 70,798 | 70,800 | 47,348 | 33,877 | 37,778 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 3,638 | 5,004 | 5,189 | 3,418 | 4,105 | 6,711 | 6,937 | ||
Accounts payable | 1,411 | 726 | |||||||
Accrued liabilities | 271 | 592 | |||||||
Employee-related liabilities | 1,606 | 1,489 | |||||||
Other undisclosed accounts payable and accrued liabilities | 350 | 5,004 | 5,189 | 3,418 | 1,298 | 6,711 | 6,937 | ||
Deferred revenue | 63 | 63 | 8 | ||||||
Debt | 36 | 1,140 | 1,141 | 1,141 | 705 | 519 | |||
Due to related parties | 64 | 51 | 33 | 26 | 80 | 29 | 22 | ||
Other liabilities | 264 | 264 | 264 | 264 | 263 | 263 | 263 | ||
Other undisclosed current liabilities | 1,074 | 1,134 | 962 | 705 | 717 | 700 | 623 | ||
Total current liabilities: | 5,040 | 6,489 | 7,651 | 5,617 | 6,314 | 8,408 | 8,364 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 2,220 | 2,640 | 5,814 | 5,324 | 7,494 | 8,122 | 7,962 | ||
Long-term debt, excluding current maturities | 78 | 87 | 96 | 2,105 | 2,548 | 2,742 | |||
Operating lease, liability | 2,220 | 2,562 | 5,727 | 5,228 | 5,389 | 5,574 | 5,220 | ||
Liabilities, other than long-term debt | 2,070 | 2,140 | 2,140 | 2,140 | 2,280 | 2,280 | 2,000 | ||
Other liabilities | 2,070 | 2,140 | 2,140 | 2,140 | 2,280 | 2,280 | 2,000 | ||
Other undisclosed noncurrent liabilities | 3,392 | 7,736 | 12,514 | 12,016 | 2,708 | 3,065 | 5,836 | ||
Total noncurrent liabilities: | 7,682 | 12,516 | 20,468 | 19,480 | 12,482 | 13,467 | 15,798 | ||
Total liabilities: | 12,722 | 19,005 | 28,119 | 25,097 | 18,796 | 21,875 | 24,162 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | 31,093 | 39,845 | 41,640 | 44,503 | 27,725 | 11,280 | 12,120 | ||
Common stock | 63 | 63 | 63 | 62 | 54 | 51 | 50 | ||
Additional paid in capital | 257,515 | 257,009 | 256,616 | 254,208 | 239,496 | 231,954 | 226,405 | ||
Accumulated other comprehensive loss | (24) | (12) | |||||||
Accumulated deficit | (226,485) | (217,203) | (215,027) | (209,767) | (211,825) | (220,725) | (214,335) | ||
Stockholders' equity attributable to noncontrolling interest | 103 | 378 | 1,039 | 1,200 | 827 | 722 | 1,496 | ||
Total stockholders' equity: | 31,196 | 40,223 | 42,679 | 45,703 | 28,552 | 12,002 | 13,616 | ||
TOTAL LIABILITIES AND EQUITY: | 43,918 | 59,228 | 70,798 | 70,800 | 47,348 | 33,877 | 37,778 |
Income statement (P&L) ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 2,171 | 2,376 | 1,405 | 828 | 7,130 | 314 | 281 | |
Cost of revenue | (11,590) | (818) | (823) | (160) | ||||
Cost of goods and services sold | (818) | (823) | (160) | |||||
Other undisclosed gross profit | (4,311) | |||||||
Gross profit: | (9,419) | 1,558 | 582 | 668 | 2,819 | 314 | 281 | |
Operating expenses | (2,585) | (11,089) | (9,088) | (6,154) | 339 | (7,895) | (7,157) | |
Other undisclosed operating income (loss) | (1,800) | 818 | 824 | 160 | 4,311 | |||
Operating income (loss): | (13,804) | (8,713) | (7,682) | (5,326) | 7,469 | (7,581) | (6,876) | |
Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (100) | (7) | 2,759 | 7,463 | 657 | 10 | ||
Interest and debt expense | 3 | (15) | (1) | (9) | (15) | (705) | 41 | |
Income (loss) from continuing operations before equity method investments, income taxes: | (13,901) | (8,735) | (4,924) | 2,128 | 8,111 | (8,286) | (6,825) | |
Other undisclosed income from continuing operations before income taxes | 9,300 | 6,570 | ||||||
Income (loss) from continuing operations before income taxes: | (4,601) | (8,735) | (4,924) | 2,128 | 14,681 | (8,286) | (6,825) | |
Income tax expense (benefit) | (1) | (1) | 139 | (9) | 10 | |||
Income (loss) before gain (loss) on sale of properties: | (4,602) | (8,736) | (4,924) | 2,128 | 14,820 | (8,295) | (6,815) | |
Other undisclosed net income (loss) | (4,955) | 5,900 | (498) | (447) | (6,212) | 1,130 | (3,079) | |
Net income (loss): | (9,557) | (2,836) | (5,422) | 1,681 | 8,608 | (7,165) | (9,894) | |
Net income attributable to noncontrolling interest | 275 | 661 | 161 | 377 | 290 | 774 | 205 | |
Other undisclosed net income attributable to parent | 0 | |||||||
Net income (loss) available to common stockholders, diluted: | (9,282) | (2,175) | (5,261) | 2,058 | 8,898 | (6,391) | (9,689) |
Comprehensive Income ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (9,557) | (2,836) | (5,422) | 1,681 | 8,608 | (7,165) | (9,894) | |
Other comprehensive loss | (12) | (12) | ||||||
Other undisclosed comprehensive income | 24 | |||||||
Comprehensive income (loss): | (9,533) | (2,848) | (5,434) | 1,681 | 8,608 | (7,165) | (9,894) | |
Comprehensive income, net of tax, attributable to noncontrolling interest | 275 | 661 | 161 | 377 | 290 | 774 | 205 | |
Other undisclosed comprehensive income, net of tax, attributable to parent | 0 | |||||||
Comprehensive income (loss), net of tax, attributable to parent: | (9,258) | (2,187) | (5,273) | 2,058 | 8,898 | (6,391) | (9,689) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.